Stocks in Play - 12th February 2026

Today in Focus: FSLY, CGNX

Sources & Services I Use in my Trading:

• Finviz - Scanning, Short Interest, Float, Fundamentals

• Benzinga Pro - News + Squawk

• Tradingview - Charting & Scanning

• BiopharmaIQ - FDA Calendars & Upcoming Biotech Catalysts

• Koyfin - Fundamental Data

• Tradersync - Trade Journal

Situational Awareness

Market Condition: QQQ Below all major Moving Averages. This is Day 5 of a bounce. DIA and RSP at All Time Highs. Still

Commentary: Still seeing good follow through on positions. Also seeing good charts. RSP and DIA at ATH. QQQ needs to get back up above MAs. Good reactions from many names in earnings and leaders emerging.

Upcoming Earnings:
After Hours: COIN, ANET, FROG, VRTX, TWLO, HASI, NUS, WYNN, CPS, LGCY, SRTS
Before Open: MRNA, AAP, CCJ

Trade Updates:

Current Positions: AEHR, VRT, NKTR, PLBY, STM, GLW, MPC, ROIV, INNV, VG, WULF

Trimmed names into strength yesterday. Everything that was bought on a Catalyst performing well. VG lagging which was a Breakout Buy.

In Play

FSLY:  Fastly delivered explosive Q4 results marking its first profitable fiscal year

Key Metrics: Industry Group: Software - Application, Market Cap: 1.99B, Float: 137.28M, Short Interest: 10.13%, Days to Cover: 3.28, Sales Y/Y TTM: 9.45%, EPS Y/Y TTM: 11.76%, Earnings: Feb 11 AMC, Exchange: NASDAQ

Catalyst: Fastly delivered explosive Q4 results marking its first profitable fiscal year, with revenue acceleration to 23% YoY (vs. 2% YoY in Q4'24), massive EPS upside (+100% vs. consensus), and operating leverage inflection. Management tone supremely confident. RPO 55% YoY Growth, NRR Acceleration

Potential for a turn around Episodic Pivot on this stock here. Big Base, genuine financial turnaround and major theme tailwinds.

CEO Kip Compton: "Our fourth quarter results mark an inflection in Fastly's growth as we achieved record revenue, gross margin, and operating profit."

Compton: "In 2025 we made significant progress on Fastly's transformation and delivered great results. As we look toward 2026, we anticipate continued momentum, with AI as an increasing tailwind for our business."

CGNX:  Return to Growth, In Theme (AI, Robotics) Growth

Key Metrics: Industry Group: Scientific & Technical Instruments, Market Cap: 7.21B, Float: 167.10M, Short Interest: 4.11%, Days to Cover: 3.92, Sales Y/Y TTM: 10.23%, EPS Y/Y TTM: 25.53%, Earnings: Feb 11 AMC, Exchange: NASDAQ

Catalyst: Cognex delivered a comprehensive beat with 6th consecutive quarter of expanding margins. Revenue beat by 7.2%, adj EPS surged 35% YoY (23.9% above consensus), and Adj EBITDA margin expanded 420 bps to 22.7%. Broad-based strength across Factory Automation (accelerated year-end spending) + continued Logistics momentum. In Theme, Return to Growth. Multi Year Base

• CEO Matt Moschner: "2025 marked a return to profitable growth for Cognex, with constant‑currency revenue growth of 8% and adjusted EPS growth of 38%"

• CEO: "We made significant progress against each of our strategic objectives, including advancing our technology leadership in AI-enabled industrial machine vision"

Delayed Reaction/Continuation Watchlist:

Monitoring:

• AR - Strong Earnings, Slower Mover, In Theme

• CROX - Strong Earnings

• SPHR - Strong Earnings

• INTC

• EGHT

Delayed Reaction Watchlist (TradingView Link)

Like what you're reading? Support this work via ☕ Ko-Fi.

_{Note: This is my methodology for identifying stocks in play. There are many valid approaches to trading catalysts—find the setups, timeframes, and risk parameters that align with your strategy.}